Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL

Qi Han, Yan Gu, Huimin Xiang, Linyao Zhang, Yan Wang, Chan Yang, Jun Li, Chelsea Steiner, Rosa Lapalombella, Jennifer A. Woyach, Yiping Yang, Sinisa Dovat, Chunhua Song, Zheng Ge

Blood blood.2024024130.

https://doi.org/10.1182/blood.2024024130

Published: 2024

Includes: Supplemental data

Journal Articles

Mitoxantrone Hydrochloride Liposome, Proteasome Inhibitors, Pomalidomide and Dexamethasone Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma in China

Menghan Liu, Jigang Wang, Haiguo Zhang, Ying Tian, Hongming Huang, Yan Wang, Qing Leng, Wenming Chen, Aijun Liu

Blood (2024) 144 (Supplement 1): 7072.

https://doi.org/10.1182/blood-2024-210174

Published: 2024

Journal Articles

Hematopoietic JAK2 V617F Mutation Increases Risk for Atrial Fibrillation

Guangshuai Teng, Ke Shang, Yuhui Zhang, Yifan Duan, Chenxiao Du, Yan Wang, Huiqin Zhang, Weiping Yuan, Yuan Zhou, Jie Bai

Blood (2024) 144 (Supplement 1): 5740.

https://doi.org/10.1182/blood-2024-206325

Published: 2024

Journal Articles

Estimating and Projecting the Number of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) By Treatment Lines in the United States

Xiaoxiao Lu, Alex Bokun, Chelsey Yang, Yan Wang, Weiye Chen, Jiamin Wang, Narendranath Epperla

Blood (2024) 144 (Supplement 1): 7618.

https://doi.org/10.1182/blood-2024-198069

Published: 2024

Journal Articles

Characterization of Hemophagocytic Lymphohistiocytosis Associated with Myeloid Neoplasms at Single-Cell Resolution

Ke Shang, Guangshuai Teng, Yuhui Zhang, Yifan Duan, Chenxiao Du, Yan Wang, Huiqin Zhang, Xuelian Cheng, Yuan Zhou, Yajing Chu, Weiping Yuan, Jie Bai

Blood (2024) 144 (Supplement 1): 4101.

https://doi.org/10.1182/blood-2024-206981

Published: 2024

Journal Articles

Clinical Characterization of Myeloid Neoplasms Patients with Fanconi Anemia Gene Mutations

Yuhui Zhang, Guangshuai Teng, Yifan Duan, Chenxiao Du, Yan Wang, Huiqin Zhang, Xin Hu, Yunhan Zhao, Yuan Zhou, Weiping Yuan, Jie Bai

Blood (2024) 144 (Supplement 1): 3175.

https://doi.org/10.1182/blood-2024-207513

Published: 2024

Journal Articles

Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma

Blood (2024) 144 (Supplement 1): 524.

https://doi.org/10.1182/blood-2024-198749

Published: 2024

Journal Articles

Real-World Effectiveness of Ravulizumab Among Adults with Atypical Hemolytic Uremic Syndrome (aHUS) Who Switched to Ravulizumab within 3 Months of Eculizumab Treatment: A Physician Panel-Based Chart Review Study (aHUS IMPACT)

Shruti Chaturvedi, Yan Wang, Moh-Lim Ong, Arpita Nag, Rui Song, Lynn Huynh, Jordan A. Burdeau, Mei Sheng Duh, Ramy Magdy Hanna

Blood (2024) 144 (Supplement 1): 2613.

https://doi.org/10.1182/blood-2024-194225

Published: 2024

Journal Articles

The Immune Inhibitory Hematopoietic Adaptor Protein Hacs1(Sly2) Suppresses the Proinflammatory Macrophage Function Contributing to Multiple Myeloma Progression

Ding Yan Wang, Ming Liu, Jamie Li, Raymond Qu, Keva Garg, Yuan Gao, Xinmiao Andrew Yang, Leqi Shen, Jingdong Wu, Xiaoyuan Liu, Derek Shiqi Xu, Cecilia Bonolo De Campos, Jinyi Zhang, Anthony Gramolini, Katherine Siminovitch, Xiao-Yan Wen, A. Keith Stewart

Blood (2024) 144 (Supplement 1): 3271.

https://doi.org/10.1182/blood-2024-209501

Published: 2024

Journal Articles

Targeted Therapy with CX4945 Biomimetic Nanodrug Delivery System for High-Risk B-Cell Acute Lymphoblastic Leukemia

Yan Wang, Fei Wang, Haoan Wu, Qi Han, Yu Zhang, Chunhua Song, Zheng Ge

Blood (2024) 144 (Supplement 1): 2788.

https://doi.org/10.1182/blood-2024-202461

Published: 2024

Journal Articles

Outpatient Administration of Brexucabtagene Autoleucel (brexu-cel) for Acute Lymphoblastic Leukemia (ALL) and Mantle Cell Lymphoma (MCL) Is Safe and Feasible

Tamer Othman, John H. Baird, Yan Wang, Stacy Pak, Ibrahim Aldoss, Ji-Lian Cai, Alexey Danilov, Tycel J. Phillips, Vaibhav Agrawal, Karamjeet S Sandhu, Matthew Mei, Paul B. Koller, Joycelynne Michelle Palmer, Stephen J. Forman, Lihua E. Budde, Ahmed Aribi

Blood (2024) 144 (Supplement 1): 2278.

https://doi.org/10.1182/blood-2024-207085

Published: 2024

Journal Articles

Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial

Lu Sun, Xiaoyang Huang, Juan Wang, Chenglu Yuan, Hongyu Zhao, Daqi Li, Ruirong Xu, Yan Wang, Ping Qin, Yan Shi, Jun Peng, Ming Hou, Yu Hou

Blood (2024) 144 (17): 1791–1799.

https://doi.org/10.1182/blood.2024025067

Published: 2024

Includes: Supplemental data

Journal Articles

Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma

Swetha Kambhampati, Reid W. Merryman, Yan Wang, Evandro Bezerra, Timothy Voorhees, Ayo S Falade, Madhav R Seshadri, Megumi Bailey, Neil Bailey, Krish Patel, Charalambos Andreadis, Adam S Kittai, Caron A Jacobson, Joycelynne Michelle Palmer, Annette Brown, Alex F. Herrera, L. Elizabeth Budde

Blood (2023) 142 (Supplement 1): 3511.

https://doi.org/10.1182/blood-2023-182467

Published: 2023

Journal Articles

Metabolomic Insights into the Pathogenesis and Prognostic Potential of Adult Acute Lymphoblastic Leukemia

Junyu Wang, Tuantuan Gui, Tong Yin, Yuting Dai, Jing Qiao, Jianfeng Li, Jie Xu, Yuanfang Liu, Yan Wang, Yun Tan, Bo Jiao, Yongmei Zhu, Zhu Chen, Wenlian Chen, Hai Fang, Jian Hou, Jian-Qing Mi, Jin Wang, Sai-Juan Chen

Blood (2023) 142 (Supplement 1): 2971.

https://doi.org/10.1182/blood-2023-184328

Published: 2023

Journal Articles

Discovery of BT-114143, a Novel and Potent Small-Molecule Plasminogen Inhibitor for Hyperfibrinolysis

Jun Tang, Sen Ji, Xiao Hu, Yan Wang, Jun Qi, Xiao Wang, Hao Wang, Jianzong Li, Zhiqiang Li, Min Li, Shaomei Zeng, Xiong Yuan, Xiaodong Zhang

Blood (2023) 142 (Supplement 1): 1229.

https://doi.org/10.1182/blood-2023-185454

Published: 2023

Journal Articles

Real-World Analysis of the Underdiagnosis, Clinical Outcomes and Associated Burden of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA) in the United States of America

Yan Wang, Andrew Rava, Marlene Smuzynski, Bonny Shah, Anusorn Thanataveerat, Imad Al Dakkak, Moh-Lim Ong, Christopher C Dvorak, Vincent Ho

Blood (2023) 142 (Supplement 1): 491.

https://doi.org/10.1182/blood-2023-177671

Published: 2023

Journal Articles

Patient Characteristics and Diagnostic Journey of Thrombotic Microangiopathy Associated with a Trigger: A Real-World, Retrospective, Multi-National Study

Yan Wang, Francesca Gatta, Joseph Conyers, Gregor Gibson, Kieran Wynne-Cattanach, Karl-Johan Myrén, Moh-Lim Ong

Blood (2023) 142 (Supplement 1): 5526.

https://doi.org/10.1182/blood-2023-179231

Published: 2023

Journal Articles

Use of Plasmic Scores to Aid Diagnosis of aHUS: A Real-World Analysis of Hospitalized Patients from the Premier Healthcare Database

Christoph Gasteyger, Miguel G Uriol-Rivera, Ana I Ávila, Robert S Makar, Frank R Ernst, John N Booth III, Angels Comas, Ching Lum, Ioannis Tomazos, Yan Wang, Pavan K. Bendapudi

Blood (2022) 140 (Supplement 1): 2780–2781.

https://doi.org/10.1182/blood-2022-155843

Published: 2022

Journal Articles

A Phase 1b Study to Evaluate Safety and Efficacy of IBI188 in Combination with Azacitidine (AZA) As a First-Line Treatment in Subjects with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Blood (2022) 140 (Supplement 1): 4045–4046.

https://doi.org/10.1182/blood-2022-155901

Published: 2022

Journal Articles

Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms

Guangshuai Teng, Yuhui Zhang, Chenxiao Du, Yan Wang, Naibo Hu, Yingdi Han, Jinyu Ma, Shan Gao, Guangpeng Xiang, Zonghong Shao, Jie Bai

Blood (2022) 140 (Supplement 1): 3959–3960.

https://doi.org/10.1182/blood-2022-168424

Published: 2022

NARROW

Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL

Mitoxantrone Hydrochloride Liposome, Proteasome Inhibitors, Pomalidomide and Dexamethasone Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma in China

Hematopoietic JAK2 V617F Mutation Increases Risk for Atrial Fibrillation

Estimating and Projecting the Number of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) By Treatment Lines in the United States

Characterization of Hemophagocytic Lymphohistiocytosis Associated with Myeloid Neoplasms at Single-Cell Resolution

Clinical Characterization of Myeloid Neoplasms Patients with Fanconi Anemia Gene Mutations

Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma

Real-World Effectiveness of Ravulizumab Among Adults with Atypical Hemolytic Uremic Syndrome (aHUS) Who Switched to Ravulizumab within 3 Months of Eculizumab Treatment: A Physician Panel-Based Chart Review Study (aHUS IMPACT)

The Immune Inhibitory Hematopoietic Adaptor Protein Hacs1(Sly2) Suppresses the Proinflammatory Macrophage Function Contributing to Multiple Myeloma Progression

Targeted Therapy with CX4945 Biomimetic Nanodrug Delivery System for High-Risk B-Cell Acute Lymphoblastic Leukemia

Outpatient Administration of Brexucabtagene Autoleucel (brexu-cel) for Acute Lymphoblastic Leukemia (ALL) and Mantle Cell Lymphoma (MCL) Is Safe and Feasible

Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial

Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma

Metabolomic Insights into the Pathogenesis and Prognostic Potential of Adult Acute Lymphoblastic Leukemia

Discovery of BT-114143, a Novel and Potent Small-Molecule Plasminogen Inhibitor for Hyperfibrinolysis

Real-World Analysis of the Underdiagnosis, Clinical Outcomes and Associated Burden of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA) in the United States of America

Patient Characteristics and Diagnostic Journey of Thrombotic Microangiopathy Associated with a Trigger: A Real-World, Retrospective, Multi-National Study

Use of Plasmic Scores to Aid Diagnosis of aHUS: A Real-World Analysis of Hospitalized Patients from the Premier Healthcare Database

A Phase 1b Study to Evaluate Safety and Efficacy of IBI188 in Combination with Azacitidine (AZA) As a First-Line Treatment in Subjects with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only